Portal fibroblasts: Underappreciated mediators of biliary fibrosis†

Cited by (273)

Items 101–200 of 273

1. Fibrotic Events in the Progression of Cholestatic Liver Disease
   Hanghang Wu, Chaobo Chen, Siham Ziani, Leonard J. Nelson, Matias Antonio Avila, Yulia Alexandrowna Nevzorova, Francisco Javier Cubero · 2021 · Cells
2. Evolution of hepatic fibrosis research
   Norifumi Kawada · 2011 · Hepatology Research
3. Cholestatic liver fibrosis and toxin-induced fibrosis are exacerbated in matrix metalloproteinase-2 deficient mice
   Izumi Onozuka, Sei Kakinuma, Akihide Kamiya, Masato Miyoshi, Naoya Sakamoto, Kei Kiyohashi, Takako Watanabe, Yusuke Funaoka, Mayumi Ueyama, Mina Nakagawa et al. · 2011 · Biochemical and Biophysical Research Communications
4. Mesodermal Mesenchymal Cells Give Rise to Myofibroblasts, but Not Epithelial Cells, in Mouse Liver Injury
   Ingrid Lua, David James, Jiaohong Wang, Kasper S. Wang, Kinji Asahina · 2014 · Hepatology
5. Platelet-derived Growth Factor Primes Cancer-associated Fibroblasts for Apoptosis
   Sumera Irie Ilyas, Joachim C. Mertens, Steven F. Bronk, Petra Hirsova, Haiming Dai, Lewis Rowland Roberts, Scott H. Kaufmann, Gregory James Gores · 2014 · Journal of Biological Chemistry
6. Expansion of prominin-1-expressing cells in association with fibrosis of biliary atresia
   Nirmala Mavila, David James, Pranavkumar Shivakumar, Marie V. Nguyen, Sarah Utley, Katrina Mak, Allison J. Wu, Shengmei Zhou, Larry L. Wang, Christopher Vendyres et al. · 2014 · Hepatology
7. Recent advances in the pathogenesis and management of biliary atresia
   Jessica Aya Zagory, Marie V. Nguyen, Kasper S. Wang · 2015 · Current Opinion in Pediatrics
8. Contribution of Myofibroblasts of Different Origins to Liver Fibrosis
   Michel Fausther, Élise G. Lavoie, Jonathan A. Dranoff · 2013 · Current Pathobiology Reports
9. HAb18G/CD147 promotes activation of hepatic stellate cells and is a target for antibody therapy of liver fibrosis
   Da-Wei Zhang, You-Xu Zhao, Ding Wei, Yalin Li, Yang Zhang, Jiao Wu, Jing Xu, Changsheng Chen, Hao Tang, Wei Zhang et al. · 2012 · Journal of Hepatology
10. Targeting PDGFR ‐β in Cholangiocarcinoma
    Christian Dominik Fingas, Joachim C. Mertens, Nataliya Razumilava, Steven F. Bronk, Alphonse Eugene Sirica, Gregory James Gores · 2011 · Liver International
11. Tackling muscle fibrosis: From molecular mechanisms to next generation engineered models to predict drug delivery
    Simone Bersini, Mara Gilardi, Marina Mora, Silke Krol, Chiara Arrigoni, Christian Candrian, Simona Zanotti, Matteo Moretti · 2018 · Advanced Drug Delivery Reviews
12. Hedgehog Signaling Demarcates a Niche of Fibrogenic Peribiliary Mesenchymal Cells
    Vikas Gupta, Ishaan Gupta, Jiwoon Park, Yaron Bram, Robert E. Schwartz · 2020 · Gastroenterology
13. Fibrogenic cell reversion underlies fibrosis regression in liver
    Scott L. Friedman · 2012 · Proceedings of the National Academy of Sciences
14. Dysregulation of redox pathways in liver fibrosis
    Natalie Julia Torok · 2016 · American Journal of Physiology-Gastrointestinal and Liver Physiology
15. Liver‐Targeted Angiotensin Converting Enzyme 2 Therapy Inhibits Chronic Biliary Fibrosis in Multiple Drug‐Resistant Gene 2‐Knockout Mice
    Indu G. Rajapaksha, Lakmie S. Gunarathne, Khashayar Asadi, Sharon C. Cunningham, Alexandra F. Sharland, Ian E. Alexander, Peter Angus, Chandana B. Herath · 2019 · Hepatology Communications
16. Alleviation of hepatic fibrosis and autophagy via inhibition of transforming growth factor‐β1/Smads pathway through shikonin
    Tong Liu, Ling Xu, Chengfen Wang, Kan Chen, Yujing Xia, Jingjing Li, Sainan Li, Liwei Wu, Jiao Feng, Shizan Xu et al. · 2018 · Journal of Gastroenterology and Hepatology
17. 3D-printed versatile biliary stents with nanoengineered surface for anti-hyperplasia and antibiofilm formation
    Hyun Lee, Dong‐Sung Won, Sinwoo Park, Yubeen Park, Ji Won Kim, Ginam Han, Yuhyun Na, Min‐Ho Kang, Seokbeom Kim, Heemin Kang et al. · 2024 · Bioactive Materials
18. Ductal Plate Malformation in the Liver of Boxer Dogs
    S. Pillai, Sean P. McDonough, JoAnn DeMarco, Jason Pintar, A. K. Henderson, J. Cooper, T. Bolton, Kristopher S. Sharpe, Steve L. Hill, A. G. Benedict et al. · 2016 · Veterinary Pathology
19. Hypoxia, hypoxia-inducible factors and fibrogenesis in chronic liver diseases.
    Stefania Cannito, Claudia Paternostro, Chiara Busletta, Claudia Bocca, Sebastiano Colombatto, Antonella Miglietta, Erica Novo, Maurizio Parola · 2014 · PubMed
20. Tumor progression locus 2/Cot is required for activation of extracellular regulated kinase in liver injury and toll-like receptor–induced TIMP-1 gene transcription in hepatic stellate cells in mice
    Maria Jesus Perugorria, Lindsay B. Murphy, Nicola Fullard, Jayashree Bagchi Chakraborty, Dimitra Vyrla, Caroline L Wilson, Fiona Oakley, Jelena Mann, Derek A. Mann · 2012 · Hepatology
21. Mathematical modeling of liver fibrosis
    Avner Friedman, Wenrui Hao · 2016 · Mathematical Biosciences & Engineering
22. Congenital Hepatic Fibrosis in Autosomal Recessive Polycystic Kidney Disease
    Jessica W. Wen · 2011 · Clinical and Translational Science
23. Hepatic Fibrosis and Cirrhosis
    Don C. Rockey · 2015 · Wiley eBooks
24. Pericytes in kidney fibrosis
    Shuyu Ren, Jeremy S. Duffield · 2013 · Current Opinion in Nephrology & Hypertension
25. Fibrin deposition following bile duct injury limits fibrosis through an αMβ2-dependent mechanism
    Nikita Joshi, Anna K. Kopec, Jessica L. Ray, Holly M. Cline-Fedewa, Atta M. Nawabi, Timothy M. Schmitt, Rance Nault, Timothy Richard Zacharewski, Cheryl Elizabeth Rockwell, Matthew J. Flick et al. · 2016 · Blood
26. Antifibrotic Effects of Human Amniotic Membrane Transplantation in Established Biliary Fibrosis Induced in Rats
    Luciana Barros Sant’Anna, Raduan Hage, Maria Angélica Gargione Cardoso, Emília Ângela Lo Schiavo Arisawa, Maria Martin Cruz, Ornella Parolini, Anna Cargnoni, Nilson Sant’Anna · 2016 · Cell Transplantation
27. The effect and mechanisms of Fuzheng Huayu formula against chronic liver diseases
    Jiamei Chen, Yonghong Hu, Long Chen, Wei Liu, Yongping Mu, Ping Liu · 2019 · Biomedicine & Pharmacotherapy
28. Aspirin attenuates liver fibrosis by suppressing TGF‑β1/Smad signaling
    Yimin Sun, Bingyan Liu, Jianping Xie, Xuefeng Jiang, Baolai Xiao, Xiaomiao Hu, Jinjian Xiang · 2022 · Molecular Medicine Reports
29. Portal fibroblasts marked by the surface antigen Thy1 contribute to fibrosis in mouse models of cholestatic liver injury
    Katsumata, Len William, Miyajima, Atsushi, Itoh, Tohru · 2017 · Hepatology Communications
30. Cancer-Associated Fibroblasts in Cholangiocarcinoma: Current Knowledge and Possible Implications for Therapy
    Michele Montori, Chiara Scorzoni, Maria Eva Argenziano, Daniele Balducci, Federico DE BLASIO, Francesco Martini, Tiziana Buono, A. Benedetti, Marco Marzioni, Luca Maroni · 2022 · Journal of Clinical Medicine
31. Oncostatin M, A Profibrogenic Mediator Overexpressed in Non-Alcoholic Fatty Liver Disease, Stimulates Migration of Hepatic Myofibroblasts
    Beatrice Foglia, Salvatore Sutti, Dario Pedicini, Stefania Cannito, Claudia Bocca, Marina Maggiora, Maria Rosaria Bevacqua, Chiara Rosso, Elisabetta Bugianesi, Emanuele Albano et al. · 2019 · Cells
32. CCL5: A Double-Edged Sword in Host Defense Against the Hepatitis C Virus
    Antonios Katsounas, JF Schlaak, Richard A. Lempicki · 2011 · International Reviews of Immunology
33. Contribution of bone marrow-derived fibrocytes to liver fibrosis.
    Jun Xu, Min Cong, Tae Jun Park, David Scholten, David A. Brenner, Tatiana Kisseleva · 2015 · Europe PMC (PubMed Central)
34. Bone marrow-derived fibrocytes contribute to liver fibrosis
    Jun Xu, Tatiana Kisseleva · 2015 · Experimental Biology and Medicine
35. Epigenetic regulation of hepatic stellate cell activation and liver fibrosis
    Adil El Taghdouini, Leo A. van Grunsven · 2016 · Expert Review of Gastroenterology & Hepatology
36. Fibrosis in the Liver
    Youngmin Lee, Scott L. Friedman · 2010 · Progress in molecular biology and translational science
37. Early Growth Response Factor-1 Limits Biliary Fibrosis in a Model of Xenobiotic-Induced Cholestasis in Mice
    Bradley P. Sullivan, Wei Cui, Bryan Lloyd Copple, James P. Luyendyk · 2011 · Toxicological Sciences
38. Reduction of galectin-3 expression and liver fibrosis after cell therapy in a mouse model of cirrhosis
    Sheilla Andrade de Oliveira, Bruno Solano de Freitas Souza, Elton Pereira de Sá Barreto, Carla Martins Kaneto, Hélio Almeida Neto, Carine Machado Azevedo, Elisalva Teixeira Guimarães, Luiz Antônio Rodrigues de Freitas, Ricardo Ribeiro‐dos‐Santos, Milena Botelho Pereira Soares · 2011 · Cytotherapy
39. Establishment and Characterization of Rat Portal Myofibroblast Cell Lines
    Michel Fausther, Jessica R. Goree, Élise G. Lavoie, Alicia L. Graham, Jean Sévigny, Jonathan A. Dranoff · 2015 · PLoS ONE
40. Tumor immune microenvironment and the current immunotherapy of cholangiocarcinoma (Review)
    Siqi Yang, Rui-Qi Zou, Yu-Shi Dai, Ya-Fei Hu, Fu‐Yu Li, Hai‐Jie Hu · 2023 · International Journal of Oncology
41. Anatomy, pathophysiology and basic mechanisms of disease
    James M. Crawford, Alastair D. Burt · 2011 · Elsevier eBooks
42. Immunotherapy-based targeting of MSLN + activated portal fibroblasts is a strategy for treatment of cholestatic liver fibrosis
    Takahiro Nishio, Yukinori Koyama, Xiao Liu, Sara Brin Rosenthal, Gen Yamamoto, Hiroaki Fuji, Jacopo Baglieri, Na Li, Laura N. Brenner, Keiko Iwaisako et al. · 2021 · Proceedings of the National Academy of Sciences
43. Oral Methylthioadenosine Administration Attenuates Fibrosis and Chronic Liver Disease Progression in Mdr2−/− Mice
    Maria Ujue Latasa, Carmen Gil, Maite G. Fernández‐Barrena, Carlos M. Rodríguez‐Ortigosa, Jesús M. Bañales, Raquel Urtasun, Saioa Goñi, Miriam Méndez, Sara Arcelus, Nerea Juanarena et al. · 2010 · PLoS ONE
44. Is it the end of the line for the EMT?
    Tatiana Kisseleva, David A. Brenner · 2011 · Hepatology
45. Geniposide suppresses liver injury in a mouse model of DDC ‐induced sclerosing cholangitis
    Min Wen, Yubei Liu, Ruiying Chen, Ping He, Feihua Wu, Rui Li, Yining Lin · 2021 · Phytotherapy Research
46. Distinct roles of ecto-nucleoside triphosphate diphosphohydrolase-2 (NTPDase2) in liver regeneration and fibrosis
    Linda Feldbrügge, Zhenghui Gordon Jiang, Eva Csizmadia, Shuji Mitsuhashi, Stephanie Tran, Eric U. Yee, Sonja Rothweiler, Kahini A. Vaid, Jean Sévigny, Moritz Schmelzle et al. · 2017 · Purinergic Signalling
47. Junctional adhesion molecules JAM-B and JAM-C promote autoimmune-mediated liver fibrosis in mice
    Edith Hintermann, Monika Bayer, Clara Benedetta Conti, Sina Fuchs, Michel Fausther, Patrick S.C. Leung, Michel Aurrand‐Lions, Richard Taubert, Josef M. Pfeilschifter, Mireen Friedrich‐Rust et al. · 2018 · Journal of Autoimmunity
48. Gardenia jasminoidesattenuates hepatocellular injury and fibrosis in bile duct-ligated rats and human hepatic stellate cells
    Yinghua Chen · 2012 · World Journal of Gastroenterology
49. Structure, Function, and Responses to Injury
    James M. Crawford, Paulette Bioulac‐Sage, Prodromos Hytiroglou · 2017 · Elsevier eBooks
50. Altered AKAP12 expression in portal fibroblasts and liver sinusoids mediates transition from hepatic fibrogenesis to fibrosis resolution
    Hye Shin Lee, Jin Hyeok Choi, Taekwon Son, Hee‐Jun Wee, Sung‐Jin Bae, Ji Hae Seo, Ji Hyun Park, Soo Hyung Ryu, Danbi Lee, Myoung Kuk Jang et al. · 2018 · Experimental & Molecular Medicine
51. The roles of Toll-like receptor 4 in the pathogenesis of pathogen-associated biliary fibrosis caused by Clonorchis sinensis
    Chao Yan, Bo Li, Fang Fan, Ying Du, Rui Ma, Xiao-Dan Cheng, Xiangyang Li, Bo Zhang, Qian Yu, Yugang Wang et al. · 2017 · Scientific Reports
52. Characteristics and Inpatient Outcomes of Primary Biliary Cholangitis and Autoimmune Hepatitis Overlap Syndrome
    Yi Jiang, Bing-Hong Xu, Brandon Rodgers, Nikolaos Pyrsopoulos · 2021 · Journal of Clinical and Translational Hepatology
53. Knockdown of miR-23, miR-27, and miR-24 alters fetal liver development and blocks fibrosis in mice
    Rogler, Charles E., Matarlo, Joe S., Kosmyna, Brian, Fulop, Daniel, Rogler, Leslie E. · 2017 · Gene Expression
54. Bacterial Translocation Is Linked to Increased Intestinal IFN-γ, IL-4, IL-17, and mucin-2 in Cholestatic Rats
    Natali Vega‐Magaña, Vidal Delgado‐Rizo, Leonel García‐Benavides, Susana del Toro‐Arreola, Jorge Enrique Segura‐Ortega, Adelaida Sara Minia Zepeda‐Morales, José Sergio Zepeda-Nuño, Marta Escarra‐Senmarti, Jorge Gutiérrez‐Franco, Jesse Haramati et al. · 2018 · Annals of Hepatology
55. microRNA-21 mediates epithelial-mesenchymal transition of human hepatocytes via PTEN/Akt pathway
    Zhenyu Liu, Jingjie Wang, Chuanyong Guo, Xiaoming Fan · 2014 · Biomedicine & Pharmacotherapy
56. Advances in the clinical use of collagen as biomarker of liver fibrosis
    Steffen K. Meurer, M.A. Karsdal, Ralf Weiskirchen · 2020 · Expert Review of Molecular Diagnostics
57. Hepatocyte-Specific Ablation of PP2A Catalytic Subunit<i>α</i>Attenuates Liver Fibrosis Progression via TGF-<i>β</i>1/Smad Signaling
    Lu, Na, Liu, Yun, Tang, An, Chen, Lulu, Miao, Dengshun, Yuan, Xiaoqin · 2015 · BioMed Research International
58. Isolation of Rat Portal Fibroblasts by In situ Liver Perfusion
    Jessica W. Wen, Abby L. Olsen, Maryna Perepelyuk, Rebecca G. Wells · 2012 · Journal of Visualized Experiments
59. Endoplasmic reticulum stress induces inverse regulations of major functions in portal myofibroblasts during liver fibrosis progression
    Emilien J. Loeuillard, Haquima El Mourabit, Lin Lei, Sara Lemoinne, Chantal Housset, Axelle Cadoret · 2018 · Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease
60. Dissecting pulmonary fibroblasts heterogeneity in lung development, health and diseases
    Xinxin Zhang, Xiaoni Shi, Feiyan Xie, Yaping Liu, Xinyan Wei, Yu Cai, Jie Chao · 2023 · Heliyon
61. Portal Fibroblasts in Biliary Fibrosis
    Rebecca G. Wells · 2014 · Current Pathobiology Reports
62. The Antifibrinolytic Drug Tranexamic Acid Reduces Liver Injury and Fibrosis in a Mouse Model of Chronic Bile Duct Injury
    Nikita Joshi, Anna K. Kopec, Keara Towery, Kurt J. Williams, James P. Luyendyk · 2014 · Journal of Pharmacology and Experimental Therapeutics
63. Revealing spatial multimodal heterogeneity in tissues with SpaTrio
    Penghui Yang, Lijun Jin, Jie Liao, Kaiyu Jin, Xin Shao, Chengyu Li, Jingyang Qian, Junyun Cheng, Dingyi Yu, Rongfang Guo et al. · 2023 · Cell Genomics
64. Immunohistochemical Characterization of Macrophages and Myofibroblasts in Fibrotic Liver Lesions Due to Fasciola Infection in Cattle
    Hossain M. Golbar, Takeshi Izawa, Vetnizah Juniantito, Chisa Ichikawa, Miyuu Tanaka, Mitsuru Kuwamura, Jyoji Yamate · 2013 · Journal of Veterinary Medical Science
65. Identifying Novel Targets for Treatment of Liver Fibrosis: What Can We Learn from Injured Tissues which Heal Without a Scar?
    Michele T. Pritchard, Jennifer M. McCracken · 2015 · Current Drug Targets
66. CK2 blockade alleviates liver fibrosis by suppressing activation of hepatic stellate cells via the Hedgehog pathway
    Junfu Fan, Gaozan Tong, Xixi Chen, Santie Li, Ying Fang Yu, Shunan Zhu, Kunxuan Zhu, Zijing Hu, Yonggan Dong, Rui Chen et al. · 2022 · British Journal of Pharmacology
67. The role of Mesothelin signaling in Portal Fibroblasts in the pathogenesis of cholestatic liver fibrosis
    Hiroaki Fuji, Grant Miller, Takahiro Nishio, Yukinori Koyama, Kevin Lam, Vivian Zhang, Rohit Seth Loomba, David A. Brenner, Tatiana Kisseleva · 2021 · Frontiers in Molecular Biosciences
68. Ketanserin, a serotonin 2A receptor antagonist, alleviates ischemia-related biliary fibrosis following donation after cardiac death liver transplantation in rats
    Liping Chen, Geng Chen, Yi-bin Guo, Lei Liu, Xiao Li, Wenmei Fan, Bingyi Shi, Yeyong Qian · 2014 · Liver Transplantation
69. Ascorbic acid is superior to silymarin in the recovery of ethanol-induced inflammatory reactions in hepatocytes of guinea pigs
    P. A. Abhilash, R. Harikrishnan, Madambath Indira · 2013 · Journal of Physiology and Biochemistry
70. Clonorchis sinensis ESPs enhance the activation of hepatic stellate cells by a cross-talk of TLR4 and TGF-β/Smads signaling pathway
    Bo Li, Chao Yan, Jing Wu, Stephane Koda, Xin Dong, Yuzhao Zhang, Yu Zhang, Qian Yu, Kuiyang Zheng · 2019 · Acta Tropica
71. Opportunities and considerations for studying liver disease with microphysiological systems on a chip
    Adiya E. Otumala, Dominick J. Hellen, C. Alessandra Luna, Priscilla Delgado, Anjana Dissanayaka, Chidozie Ugwumadu, Oluwamayokun T. Oshinowo, Md. Mydul Islam, Luyao Shen, Saul J. Karpen et al. · 2023 · Lab on a Chip
72. The origins, roles and therapies of cancer associated fibroblast in liver cancer
    Natasha Zulaziz, San Jiun Chai, Kue Peng Lim · 2023 · Frontiers in Oncology
73. Transient Receptor Potential Vanilloid-1 (TRPV1) Alleviates Hepatic Fibrosis via TGF-β Signaling
    Ke Qian, Xiaohua Lei, Guoxing Liu, Yu Fang, Chengzhi Xie, Xiaolong Wu, Qiang Liu, Gao Liu, Zhenyu Cao, Ju Zhang et al. · 2022 · Disease Markers
74. CCL5 mRNA is a marker for early fibrosis in chronic hepatitis C and is regulated by interferon‐α therapy and toll‐like receptor 3 signalling
    Antonios Katsounas, Martin Trippler, B. Wang, Michael Alan Polis, Richard A. Lempicki, Shyam Kottilil, Guido Gerken, JF Schlaak · 2011 · Journal of Viral Hepatitis
75. Cancer-associated fibroblasts in hepatocellular carcinoma: origins, heterogeneity, and therapeutic implications
    Xin Shi, Weixiong Zhu, Jianpeng Zhang, Chuanlei Fan, Jing Zhang · 2025 · Frontiers in Immunology
76. Hepatic Myofibroblasts: A Heterogeneous and Redox-Modulated Cell Population in Liver Fibrogenesis
    Claudia Bocca, Francesca Protopapa, Beatrice Foglia, Marina Maggiora, Stefania Cannito, Maurizio Parola, Erica Novo · 2022 · Antioxidants
77. Hypoxia-induced factor and its role in liver fibrosis
    Jan Mohammad Omar, Yang Hai, Shizhu Jin · 2022 · PeerJ
78. Hepatic Fibrosis and Cirrhosis
    Don C. Rockey, Scott L. Friedman · 2012 · Elsevier eBooks
79. Anatomy and Cellular Functions of the Liver
    Lihui Qin, James M. Crawford · 2018 · Elsevier eBooks
80. New insights on the pathogenesis of biliary cirrhosis provided by studies in FXR knockout mice
    Michel Fausther, Jonathan A. Dranoff · 2011 · Journal of Hepatology
81. Expression of mediators of purinergic signaling in human liver cell lines
    Jessica R. Goree, Élise G. Lavoie, Michel Fausther, Jonathan A. Dranoff · 2014 · Purinergic Signalling
82. Evidence for a “Pathogenic Triumvirate” in Congenital Hepatic Fibrosis in Autosomal Recessive Polycystic Kidney Disease
    Lu Jiang, Pingping Fang, James L. Weemhoff, Udayan M. Apte, Michele T. Pritchard · 2016 · BioMed Research International
83. Role of Integrin αvβ6 in the Pathogenesis of Ischemia-Related Biliary Fibrosis After Liver Transplantation
    Geng Chen, Leida Zhang, Liping Chen, Huaizhi Wang, Yujun Zhang, Ping Bie · 2013 · Transplantation
84. STING Activation in Various Cell Types in Metabolic Dysfunction‐Associated Steatotic Liver Disease
    JingJing Wang, Yue Guo, Jing Hu, Jinghua Peng · 2025 · Liver International
85. Coffee, adenosine, and the liver
    Jonathan A. Dranoff · 2023 · Purinergic Signalling
86. Immunohistological analysis on distribution of smooth muscle tissues in livers of various vertebrates with attention to different liver architectures
    Noriaki Ota, Haruka Hirose, Hideaki Kato, Hikari Maeda, Nobuyoshi Shiojiri · 2020 · Annals of Anatomy - Anatomischer Anzeiger
87. Polo‐like kinase 3 is associated with improved overall survival in cholangiocarcinoma
    Benjamin Juntermanns, Svenja Sydor, Gernot M. Kaiser, Derar Jaradat, Joachim C. Mertens, Georgios Charalambos Sotiropoulos, Sandra Swoboda, Jan Peter Neuhaus, Wei Meng, Zoltán Máthé et al. · 2015 · Liver International
88. Periductal fibroblasts participate in liver homeostasis, fibrosis, and tumorigenesis
    Shan-Shan Wang, Jia Yuan, Xinyu Thomas Tang, Xiujuan Yin, Ke Fang, Lin Veronica Chen, Zhenggang Ren, Bo O. Zhou · 2025 · The Journal of Experimental Medicine
89. Regression of Liver Fibrosis
    Maria Guido · 2018 · Elsevier eBooks
90. Noninvasive Diagnostic and Prognostic Assessment Tools for Liver Fibrosis and Cirrhosis in Patients with Chronic Liver Disease
    Ju‐Seop Kang, Min‐Ho Lee · 2017 · InTech eBooks
91. The role and immunophenotypic characteristics of myofibroblasts in liver of sheep naturally infected with the lancet liver fluke (Dicrocoelium dendriticum)
    Vladimir Kukolj, Sanja Aleksić‐Kovačević, Sofija Katić-Radivojević, Djordje Knežević, M. Jovanović · 2015 · Veterinary Parasitology
92. Myofibroblastic reaction is a common event in metastatic disease of breast carcinoma: a descriptive study
    Xavier Catteau, Philippe Simon, Jean‐Christophe Noël · 2014 · Diagnostic Pathology
93. Stellate Cells, Portal Myofibroblasts, and Epithelial-to-Mesenchymal Transition
    Yukinori Koyama, Ping Wang, David A. Brenner, Tatiana Kisseleva · 2015 · Elsevier eBooks
94. Bile Acid Metabolism During Development
    Heidi Eigenrauch Karpen, Saul J. Karpen · 2016 · Elsevier eBooks
95. Changes of biliary cilia, smooth muscle tissue distribution, innervation and extracellular matrices during morphological evolution of hepatic architectures in vertebrates
    Nobuyoshi Shiojiri, Haruka Hirose, Noriaki Ota, Junri Sekiguchi, Sachie Matsubara, Hayato Kawakami · 2023 · Annals of Anatomy - Anatomischer Anzeiger
96. The tumor microenvironment in hepatocarcinoma: dissecting the functions of cancer-associated fibroblasts
    Massimiliano Cadamuro, Giorgia Nuozzi, Paolo Simioni, Luca Fabris · 2023 · Hepatoma Research
97. Chinese herbal decoction, Yi-Qi-Jian-Pi formula exerts anti-hepatic fibrosis effects in mouse models of CCl4-induced liver fibrosis
    Shiyan Yang, Yajun Cheng, Xiaolong Wang, Suyang Yue, Xi Wang, Li Tang, Hailun Li, Jie Zhang, Qingping Xiong, Shanzhong Tan · 2024 · Heliyon
98. Biliary fibrosis is an important but neglected pathological feature in hepatobiliary disorders: from molecular mechanisms to clinical implications
    Jinyu Zhao, Ping Yue, Ningning Mi, Matu Li, Wenkang Fu, Xianzhuo Zhang, Long Gao, Mingzhen Bai, Liang Tian, Ningzu Jiang et al. · 2024 · Medical Review
99. The Role of Mesothelin in Activation of Portal Fibroblasts in Cholestatic Liver Injury
    Takahiro Nishio, Yukinori Koyama, Hiroaki Fuji, Kei Ishizuka, Keiko Iwaisako, Kojiro Taura, Etsuro Hatano, David A. Brenner, Tatiana Kisseleva · 2022 · Biology
100. A Comprehensive Review of Liver Allograft Fibrosis and Steatosis: From Cause to Diagnosis
     Madhumitha Rabindranath, Rita Zaya, Khairunnadiya Prayitno, Ani Orchanian‐Cheff, Keyur Patel, Elmar Jaeckel, Mamatha Bhat · 2023 · Transplantation Direct